Commercialising Cell and Gene Therapies: From Idea to Patient Impact

Join us for a dynamic, interactive event bringing together the people, expertise and perspectives that drive the translation of cell and gene therapy innovations from bench to bedside. This half‑day event marks the launch of our North of England Cross‑Sector Hub, hosted by the Northern Health Science Alliance (NHSA), creating a new regional focal point for collaboration across academia, the NHS, industry, patient involvement and other key stakeholders.  

This event will foster meaningful cross‑sector connections, offer practical insights from expert speakers, and create space for new collaborations that accelerate patient impact. 

This event is open to researchers across all academic career stages, Academy of Medical Sciences Fellows, clinical and NHS colleagues, cell and gene therapy industry partners, patient advocates and public contributors, third sector organisations and innocation ecosystem partners.

If you are interested in attending contact [email protected]

Discussions exploring pressing cell and gene therapy challenges, include: 

• What successful cell and gene therapy translation really requires 
• The journey to successful commercialisation for patient benefit 
• How the northern ecosystem can support researchers and clinicians 

The event is being held in collaboration with the British Society of Gene and Cell Therapy (BSGCT) Annual Conference 2026.